Literature DB >> 17094922

Strategies for managing antidepressant-induced sexual dysfunction: a review.

Matthew J Taylor1.   

Abstract

Sexual dysfunction is a common side effect of most antidepressants. Lower rates are reported with some newer agents such as reboxetine and bupropion. The evidence base for its management is limited but growing, with most approaches only tested in a small number of trials. Available strategies include watchful waiting, the use of short drug holidays, and a change of antidepressant. Many specific antidotes have been trialed but with lack of convincing benefit in most cases. However, where antidepressants cause erectile dysfunction, the use of sildenafil has the largest and most consistent evidence base.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17094922     DOI: 10.1007/s11920-006-0047-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  32 in total

1.  Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study.

Authors:  P S Masand; A K Ashton; S Gupta; B Frank
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

2.  Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment.

Authors:  C C Coleman; L A Cunningham; V J Foster; S R Batey; R M Donahue; T L Houser; J A Ascher
Journal:  Ann Clin Psychiatry       Date:  1999-12       Impact factor: 1.567

3.  Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

Authors:  Pedro L Delgado; Stephen K Brannan; Craig H Mallinckrodt; Pierre V Tran; Robert K McNamara; Fujun Wang; John G Watkin; Michael J Detke
Journal:  J Clin Psychiatry       Date:  2005-06       Impact factor: 4.384

4.  Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial.

Authors:  David Michelson; Kristen Kociban; Roy Tamura; Mary F Morrison
Journal:  J Psychiatr Res       Date:  2002 May-Jun       Impact factor: 4.791

5.  Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.

Authors:  M Landén; E Eriksson; H Agren; T Fahlén
Journal:  J Clin Psychopharmacol       Date:  1999-06       Impact factor: 3.153

6.  Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors.

Authors:  H G Nurnberg; A Gelenberg; T B Hargreave; W M Harrison; R L Siegel; M D Smith
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

7.  Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.

Authors:  A L Montejo; G Llorca; J A Izquierdo; F Rico-Villademoros
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

Review 8.  Strategies for managing sexual dysfunction induced by antidepressant medication.

Authors:  Lisa Rudkin; Matthew J Taylor; Keith Hawton
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

9.  Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs.

Authors:  David Wheatley
Journal:  Hum Psychopharmacol       Date:  2004-12       Impact factor: 1.672

10.  A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction.

Authors:  Cindy M Meston
Journal:  J Sex Marital Ther       Date:  2004 Mar-Apr
View more
  6 in total

1.  [Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].

Authors:  S Cohen; K U Kühn; B Sträter; N Scherbaum; W Weig
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

2.  Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.

Authors:  Jutatip Guptarak; Jhimly Sarkar; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2010-03-08       Impact factor: 3.587

3.  Management of hypoactive sexual desire disorder in women: current and emerging therapies.

Authors:  Rossella E Nappi; Ellis Martini; Erica Terreno; Francesca Albani; Valentina Santamaria; Silvia Tonani; Luca Chiovato; Franco Polatti
Journal:  Int J Womens Health       Date:  2010-08-09

4.  [Sexual dysfunction in remittent depressive women].

Authors:  A Baranyi; A Stepan; H-B Rothenhäusler
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

5.  Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.

Authors:  C Derzko; S Elliott; W Lam
Journal:  Curr Oncol       Date:  2007-12       Impact factor: 3.677

6.  Perspectives on Sexual Health and Function of Recent Male Combat Veterans of Iraq and Afghanistan.

Authors:  Drew A Helmer; Gregory Beaulieu; Catherine Powers; Cheryl Houlette; David Latini; Michael Kauth
Journal:  Sex Med       Date:  2015-05-08       Impact factor: 2.491

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.